De‐Hua Chang
Papers
1
Total Citations
36
H-Index
1
About
De-Hua Chang is a leading radiation oncologist whose research focuses on the intersection of precision radiotherapy and thoracic oncology, particularly for inoperable lung cancers. His most cited work, a 2017 study on risk-adapted robotic stereotactic body radiation therapy (SBRT) for early-stage non-small-cell lung cancer, has garnered 36 citations and demonstrates his commitment to tailoring high-dose, ablative radiation to individual patient risk profiles. This contribution has helped refine SBRT protocols, improving tumor control while minimizing toxicity in patients who cannot undergo surgery. Beyond this landmark paper, Chang’s broader research integrates advanced imaging, motion management, and dose fractionation strategies to enhance the therapeutic ratio in lung cancer. His work has influenced clinical guidelines and inspired further investigation into personalized radiation delivery. With a career dedicated to translating technological innovation into tangible patient benefits, Chang remains a pivotal figure in the evolution of stereotactic body radiation therapy, offering new hope for those with limited treatment options.
Research Focus
Key Achievements
Top Papers
- 1